
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.650 | 0.650 | 0.000 |
Shares | 99.350 | 99.350 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 33.610 | 35.009 |
Price to Book | 2.528 | 3.883 |
Price to Sales | 4.989 | 5.038 |
Price to Cash Flow | 18.134 | 23.817 |
Dividend Yield | 0.933 | 0.883 |
5 Years Earnings Growth | 13.899 | 13.241 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.870 | 96.854 |
Basic Materials | 1.130 | 4.452 |
Number of long holdings: 43
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 9.42 | 1,631.60 | -1.30% | |
Cipla | INE059A01026 | 5.68 | 1,494.60 | -1.24% | |
Ajanta Pharma Ltd | INE031B01049 | 5.38 | 2,411.00 | -1.96% | |
Lupin | INE326A01037 | 4.57 | 1,905.60 | -1.00% | |
Dr Reddy’s Laboratories | INE089A01031 | 4.06 | 1,234.50 | -1.12% | |
Procter & Gamble Health | INE199A01012 | 3.99 | 6,234.50 | 0.00% | |
Fortis Healthcare | INE061F01013 | 3.79 | 1,055.35 | +1.30% | |
Glenmark Pharma | INE935A01035 | 3.78 | 1,929.30 | -1.70% | |
Apollo Hospitals | INE437A01024 | 3.61 | 7,662.00 | -0.49% | |
Alkem Laboratories Ltd | INE540L01014 | 3.41 | 5,493.50 | +0.03% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UTI Equity Fund Growth | 255.09B | 1.60 | 9.61 | 12.36 | ||
UTI Equity Fund Dividend Payout | 255.09B | 1.60 | 9.58 | 12.24 | ||
UTI Equity Fund Growth Option D | 255.09B | 2.02 | 10.40 | 13.07 | ||
UTI Equity Fund Income Option D | 255.09B | 2.02 | 10.37 | 12.95 | ||
UTI Mastershare Unit Growth | 129.48B | 3.29 | 11.48 | 11.75 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review